Literature DB >> 19854810

Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis.

U Heidenreich1, G Mayer, M Herold, W Klotz, K Stempfl Al-Jazrawi, K Lhotta.   

Abstract

Several studies have investigated the potential of various autoantibody tests in the diagnosis of systemic lupus erythematosus (SLE). Many lupus patients initially present with glomerulonephritis. In that clinical situation the main differential diagnosis are other forms of glomerulonephritis. In this study the diagnostic value of nine test kits for autoantibody against ANA, dsDNA, circulating immune complexes, C1q, nucleosomes, histones and Sm as well as C3 and C4 levels was evaluated in 39 patients with biopsy-proven lupus nephritis in comparison to 43 patients suffering from other forms of glomerulonephritis. The most useful test was an anti-nucleosome antibody enzyme-linked immunosorbent assay (ELISA) with a sensitivity of 90% and a specificity of 88%. All tests for anti-dsDNA antibodies (Crithidia luciliae Anti-dsDNA, BINDAZYME Anti-dsDNA, FARRZYME high avidity Anti-dsDNA) were of moderate sensitivity and very good specificity. Decreasing the cut-off for the conventional anti-dsDNA ELISA (BINDAZYME) considerably increased its sensitivity (87%) without loss of specificity (90%). Tests for anti-C1q and immune complexes performed worse than the antidsDNA tests. As anti-histone and Sm antibodies are present only in a minority of lupus nephritis patients they are of limited value in diagnosing the disease. In conclusion, testing for anti-nucleosome antibodies and the conventional anti-dsDNA ELISA with lower cut-off provide the best diagnostic aids for differentiation of lupus nephritis from other forms of glomerulonephritis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19854810     DOI: 10.1177/0961203309345753

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  Evaluation of a high avidity anti-dsDNA IgG enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus.

Authors:  Brenda B Suh-Lailam; Tyson R Chiaro; Wayne Davis K; Andrew R Wilson; Anne E Tebo
Journal:  Int J Clin Exp Pathol       Date:  2011-10-30

2.  Anti-DNase I antibodies in systemic lupus erythematosus: diagnostic value and share in the enzyme inhibition.

Authors:  A S Trofimenko; I P Gontar; A B Zborovsky; O V Paramonova
Journal:  Rheumatol Int       Date:  2016-02-15       Impact factor: 2.631

Review 3.  Preclinical Autoimmune Disease: a Comparison of Rheumatoid Arthritis, Systemic Lupus Erythematosus, Multiple Sclerosis and Type 1 Diabetes.

Authors:  Giulia Frazzei; Ronald F van Vollenhoven; Brigit A de Jong; Sarah E Siegelaar; Dirkjan van Schaardenburg
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

4.  Significance of circRNAs as biomarkers for systemic lupus erythematosus: a systematic review and meta-analysis.

Authors:  Luyuan Wang; Mengting Lu; Wenyu Li; Runge Fan; Sijian Wen; Wen Xiao; Youkun Lin
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

5.  Anti-C1q in systemic lupus erythematosus.

Authors:  G Stojan; M Petri
Journal:  Lupus       Date:  2016-07       Impact factor: 2.911

6.  An Overlapping Case of Lupus Nephritis and IgG4-Related Kidney Disease.

Authors:  Mazen Zaarour; Chanudi Weerasinghe; Ahmad Eter; Suzanne El-Sayegh; Elie El-Charabaty
Journal:  J Clin Med Res       Date:  2015-05-08

7.  Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis.

Authors:  Jürgen Dieker; Jo H Berden; Marinka Bakker; Jean-Paul Briand; Sylviane Muller; Reinhard Voll; Christopher Sjöwall; Martin Herrmann; Luuk B Hilbrands; Johan van der Vlag
Journal:  PLoS One       Date:  2016-10-25       Impact factor: 3.240

Review 8.  Potential serum and urine biomarkers in patients with lupus nephritis and the unsolved problems.

Authors:  Song-Chou Hsieh; Chang-Youh Tsai; Chia-Li Yu
Journal:  Open Access Rheumatol       Date:  2016-09-19

9.  Anti-C1q autoantibodies, novel tests, and clinical consequences.

Authors:  Michael Mahler; Rosanne A van Schaarenburg; Leendert A Trouw
Journal:  Front Immunol       Date:  2013-05-14       Impact factor: 7.561

10.  High Avidity dsDNA Autoantibodies in Brazilian Women with Systemic Lupus Erythematosus: Correlation with Active Disease and Renal Dysfunction.

Authors:  Rodrigo C Oliveira; Isabela S Oliveira; Mittermayer B Santiago; Maria L B Sousa Atta; Ajax M Atta
Journal:  J Immunol Res       Date:  2015-10-25       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.